150 related articles for article (PubMed ID: 38141263)
1. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
[No Abstract] [Full Text] [Related]
4. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and precision of contrast enhanced mammography versus MRI for predicting breast cancer size: how "good" are they really?
Taylor DB; Burrows S; Dessauvagie BF; Saunders CM; Ives A
Br J Radiol; 2023 Mar; 96(1144):20211172. PubMed ID: 36753450
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
Zhang C; Kosiorek HE; Patel BK; Pockaj BA; Ahmad SB; Cronin PA
Ann Surg Oncol; 2022 Oct; 29(10):6207-6212. PubMed ID: 35831526
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
11. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.
Giannotti E; Van Nijnatten TJA; Chen Y; Bicchierai G; Nori J; De Benedetto D; Lalji U; Lee AHS; James J
Clin Radiol; 2024 Jun; 79(6):e799-e806. PubMed ID: 38383254
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
[TBL] [Abstract][Full Text] [Related]
13. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
[TBL] [Abstract][Full Text] [Related]
14. Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
Terzoni A; Basile P; Gambaro AC; Attanasio S; Rampi AM; Brambilla M; Carriero A
Radiol Med; 2024 Apr; 129(4):558-565. PubMed ID: 38512618
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
[TBL] [Abstract][Full Text] [Related]
16. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
17. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
19. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
[TBL] [Abstract][Full Text] [Related]
20. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
